D'Egidio M - Search Results

1

Lipoprotein 90K in human immunodeficiency virus-infected patients: a further serologic marker of progression.

Iacobelli S, Natoli C, D'Egidio M, Tamburrini E, Antinori A, Ortona L. Iacobelli S, et al. J Infect Dis. 1991 Oct;164(4):819. doi: 10.1093/infdis/164.4.819. J Infect Dis. 1991. PMID: 1894946 No abstract available.

2

A 90-kDa protein serum marker for the prediction of progression to AIDS in a cohort of HIV-1+ homosexual men.

Briggs NC, Natoli C, Tinari N, D'Egidio M, Goedert JJ, Iacobelli S. Briggs NC, et al. AIDS Res Hum Retroviruses. 1993 Sep;9(9):811-6. doi: 10.1089/aid.1993.9.811. AIDS Res Hum Retroviruses. 1993. PMID: 7504933

3

The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection.

Iacobelli S, Ullrich A, Tinari N, Ortona L, Tamburrini E, D'Egidio M, Ghinelli F, Sighinolfi L, Piazza M, Chirianni A, et al. Iacobelli S, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 1;10(4):450-6. doi: 10.1097/00042560-199512000-00008. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7583441

4

Elevated serum levels of a 90,000 daltons tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV).

Natoli C, Ortona L, Tamburrini E, Tinari N, Di Stefano P, D'Egidio M, Ghinelli F, Sighinolfi L, D'Ostilio N, Piazza M, et al. Natoli C, et al. Anticancer Res. 1994 May-Jun;14(3B):1457-60. Anticancer Res. 1994. PMID: 8067721

5

Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients.

Artini M, Natoli C, Tinari N, Costanzo A, Marinelli R, Balsano C, Porcari P, Angelucci D, D'Egidio M, Levrero M, Iacobelli S. Artini M, et al. J Hepatol. 1996 Aug;25(2):212-7. doi: 10.1016/s0168-8278(96)80076-6. J Hepatol. 1996. PMID: 8878784

6

90K (Mac-2 BP) and galectins in tumor progression and metastasis.

Grassadonia A, Tinari N, Iurisci I, Piccolo E, Cumashi A, Innominato P, D'Egidio M, Natoli C, Piantelli M, Iacobelli S. Grassadonia A, et al. Glycoconj J. 2002;19(7-9):551-6. doi: 10.1023/B:GLYC.0000014085.00706.d4. Glycoconj J. 2002. PMID: 14758079 Review.

7

The secreted tumor-associated antigen 90K is a potent immune stimulator.

Ullrich A, Sures I, D'Egidio M, Jallal B, Powell TJ, Herbst R, Dreps A, Azam M, Rubinstein M, Natoli C, et al. Ullrich A, et al. J Biol Chem. 1994 Jul 15;269(28):18401-7. J Biol Chem. 1994. PMID: 8034587 Free article.

8

Prognostic value of a novel circulating serum 90K antigen in breast cancer.

Iacobelli S, Sismondi P, Giai M, D'Egidio M, Tinari N, Amatetti C, Di Stefano P, Natoli C. Iacobelli S, et al. Br J Cancer. 1994 Jan;69(1):172-6. doi: 10.1038/bjc.1994.29. Br J Cancer. 1994. PMID: 8286203 Free PMC article. Clinical Trial.

9

Dynamic test with recombinant interferon-alpha-2b: effect on 90K and other tumour-associated antigens in cancer patients without evidence of disease.

Natoli C, Garufi C, Tinari N, D'Egidio M, Lesti G, Gaspari LA, Visini R, Iacobelli S. Natoli C, et al. Br J Cancer. 1993 Mar;67(3):564-7. doi: 10.1038/bjc.1993.103. Br J Cancer. 1993. PMID: 8439505 Free PMC article.

10

Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines.

Iacobelli S, Bucci I, D'Egidio M, Giuliani C, Natoli C, Tinari N, Rubistein M, Schlessinger J. Iacobelli S, et al. FEBS Lett. 1993 Mar 15;319(1-2):59-65. doi: 10.1016/0014-5793(93)80037-u. FEBS Lett. 1993. PMID: 8454062 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters